PUBLISHER: Polaris Market Research | PRODUCT CODE: 1651968
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1651968
The global specialty enzymes market size is expected to reach USD 13.86 billion by 2034, according to a new study by Polaris Market Research. The report "Specialty Enzymes Market Size, Share, Trends, Industry Analysis Report: By Source (Animal, Microorganisms, and Plant), Type, Form, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The specialty enzymes market growth is driven by advancements in enzyme engineering, including the application of artificial intelligence (AI) and machine learning (ML) to advance designer enzyme development. Several biotech firms are using AI and ML to predict suitable enzymes for experimental screening and to address the limitations of current methods. In December 2023, Neochromosome, Inc., a biotech company focused on genome-scale cell engineering, collaborated with Dr. Giovanni Stracquadanio from the University of Edinburgh to harness the potential of AI and ML in designer enzyme development. These types of technological adoptions improve the development and optimization of enzymes by enabling quick analysis and prediction of enzyme properties, structures, and functions. Therefore, integrating AI and ML in enzyme engineering fosters innovation and expands the specialty enzymes market worldwide.
The rising shift toward biocatalysts, which are enzymes or cells used to accelerate chemical reactions, is driving the specialty enzymes market expansion. Biocatalysts are preferred over regular chemical catalysts due to their efficiency, specificity, and environmental benefits. Biocatalysts operate under mild conditions, reducing the need for harsh chemicals and high energy inputs, which aligns with the growing emphasis on sustainability and green chemistry. Thus, the demand for specialty enzymes as biocatalysts is rising as industries seek eco-friendly and cost-effective solutions.
The biotechnology and pharmaceutical industries are major consumers of specialty enzymes due to their critical role in drug development, diagnostics, and therapeutic applications. Enzymes are used in processes such as the synthesis of pharmaceutical compounds, bioassays, and personalized medicine. Consequently, the demand for specialty enzymes to support complex processes and enhance product efficacy grows as these industries expand and innovate, driving market growth.
Based on type, the proteases segment is anticipated to experience substantial growth at a significant CAGR in the global market. This growth is attributed to the indispensable role and adaptability of specialty enzymes in various industries.
The pharmaceuticals segment, by application, accounted for the largest revenue share of the market in 2024 due to the growth of the pharma industry driven by increased demand for drug development and production.
In 2024, North America dominated the global specialty enzymes market revenue share due to the presence of several established companies within the region.
The specialty enzymes market in China is projected for substantial growth due to the regulatory support for biotech innovations within the country.
A few global key market players are 4basebio; Advanced Enzyme Technologies; Amano Enzyme Inc.; Aumgene Biosciences; BASF SE; BBI Solutions; Bioseutica; Codexis, Inc.; Dyadic International Inc; Enzyme Bioscience Private Limited; F. Hoffmann-La Roche Ltd; Merck KGaA; New England Biolabs; S.I. Biozyme; Sanofi; SEKISUI Diagnostics; and Thermo Fisher Scientific Inc.
Polaris Market Research has segmented the specialty enzymes market report on the basis of source, type, form, application, and region: